Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss

• मुख्य लेखकों: Richard D. Lutze (लेखक), Matthew A. Ingersoll (लेखक), Regina G. Kelmann (लेखक), Tal Teitz (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2024-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Hearing loss is one of the most common types of disability; however, there is only one FDA-approved drug to prevent any type of hearing loss. Treatment with the highly effective chemotherapy agent, cisplatin, and exposure to high-decibel noises are two of the most common causes of hearing loss. The...